Moderna
MRNA
#419
Rank
$46.42 B
Marketcap
$121.14
Share price
-0.15%
Change (1 day)
-2.91%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -$4.77 B

According to Moderna 's latest financial reports the company's current earnings (TTM) are -$4.77 B. In 2023 the company made an earning of -$3.91 B a decrease over its 2022 earnings that were of $9.60 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$4.77 B22.11%
2023 -$3.91 B-140.65%
2022 $9.60 B-27.81%
2021 $13.30 B-1911.15%
2020 -$0.74 B44.7%
2019 -$0.51 B28.63%
2018 -$0.4 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$30.87 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.11 B-207.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-$41.77 M-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.2 B-95.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.82 B-306.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$0.46 B-90.45%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.36 B-548.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.12 B-97.53%๐Ÿ‡บ๐Ÿ‡ธ USA